Staging Computed Tomography Parameters Predict the Need for Vein Resection during Pancreaticoduodenectomy in Resectable Pancreatic Ductal Adenocarcinoma

Author:

Pande Rupaly1,Liu Wingyan2,Raza Syed S.1,Papamichail Michail1,Suthananthan Arul E.1ORCID,Bartlett David C.1ORCID,Marudanayagam Ravi1,Dasari Bobby V. M.1,Sutcliffe Robert P.1,Roberts Keith J.13,Wadhwani Sharan2ORCID,Chatzizacharias Nikolaos14

Affiliation:

1. Department of HPB and Liver Transplant Surgery, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK

2. Department of Radiology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK

3. Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK

4. College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK

Abstract

Background: Surgery-first approach is the current standard of care for resectable pancreatic ductal adenocarcinoma (PDAC), and a proportion of these cases will require venous resection. This study aimed to identify parameters on staging computed tomography (CT) that predict the need for venous resection during pancreaticoduodenectomy (PD) for resectable PDAC. Methods: We conducted a retrospective analysis of prospectively collected data on patients who underwent PD for resectable staged PDAC (as per NCCN criteria) between 2011 and 2020. Staging CTs were independently reviewed by two specialist radiologists blinded to the clinical outcomes. Univariate and multivariate risk analyses were performed. Results: In total, 296 PDs were included. Venous resection was performed in 62 (21%) cases. There was a higher rate of resection margin positivity in the vein resection group (72.6% vs. 48.7%, p = 0.001). Tumour at the neck of the pancreas, superior mesenteric vein involvement of ≥10 mm and pancreatic duct dilatation were identified as independent predictors for venous resection. Discussion: Staging CT parameters can predict the need for venous resection during PD for resectable cases of PDAC. This may assist in surgical planning, patient selection and counselling. Future efforts should concentrate on validating these results or identifying additional predictors in a multicentre and prospective setting.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference35 articles.

1. Pancreatic Cancer UK (2023, November 01). Pancreatic Cancer Statistics. Available online: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer#:~:text=Pancreatic%20cancer%20incidence,cases%20(2016%2D2018).

2. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ducreux;Ann. Oncol.,2015

3. Pancreatic Adenocarcinoma Guidelines (2023, November 01). National Comprehensive Cancer Network Version 2.2023. Available online: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.

4. Defining Benchmark. Outcomes for Pancreatoduodenectomy With Portomesenteric Venous Resection;Raptis;Ann. Surg.,2020

5. Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: Impact on short- and long-term outcomes in a nationwide cohort analysis;Groen;Br. J. Surg.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3